Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,734,752
+$574,021 QoQ
Shares Held
81,258
+2.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#149
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $211,410,302 across 13 Drug Manufacturers - General names. NVS ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,968 | $64,730,841 | |
| 2 | JNJ |
Johnson & Johnson
|
138,783 | $35,246,716 | |
| 3 | ABBV |
AbbVie Inc.
|
126,735 | $31,891,592 | |
| 4 | AZN |
Astrazeneca PLC
|
85,578 | $16,227,298 | |
| 5 | MRK |
Merck & Co., Inc.
|
111,985 | $14,390,071 | |
| 6 | NVS |
Novartis AG
This page
|
81,258 | $12,734,752 | |
| 7 | AMGN |
Amgen Inc
|
28,753 | $10,412,035 | |
| 8 | PFE |
Pfizer Inc
|
335,343 | $8,075,058 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,734,752 | 81,258 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $12,160,731 | 79,612 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $12,998,658 | 94,282 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $1,197,503 | 9,338 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,649,486 | 13,631 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $937,992 | 8,414 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $833,362 | 8,564 | Shares | Other | 2025-02-06 | |
| 2024-09-30 | $977,554 | 8,499 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $1,266,979 | 11,901 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,558,513 | 16,112 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,702,960 | 16,866 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,476,970 | 14,500 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,687,268 | 46,450 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,579,852 | 49,781 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $4,507,422 | 49,685 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $3,813,801 | 50,175 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $2,963,452 | 35,058 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,223,408 | 36,734 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,726,964 | 31,176 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,446,448 | 29,915 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,551,709 | 27,967 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,152,813 | 25,185 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,621,471 | 27,761 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,889,593 | 33,229 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,961,175 | 33,904 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,820,614 | 34,210 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||